OraSure Technologies | OSUR - Equity Capital And Reserves


OraSure Technologies reported $317.78M in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Agilent USD 7.12B 214M Mar/2026
AngioDynamics USD 176.33M 2.52M Sep/2025
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Bio Techne USD 2.09B 74.32M Mar/2026
Bio-Rad Laboratories USD 7.17B 322.6M Jun/2026
Bruker USD 2.44B 67M Jun/2026
Cerus USD 64.22M 2.76M Dec/2025
Charles River Laboratories USD 2.84B 59.06M Jun/2026
Danaher USD 52.58B 368M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Dexcom USD 2.62B 335.5M Jun/2026
Illumina USD 2.84B 162M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 18.17B 693.9M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
Mesa Laboratories USD 186.69M 8.22M Dec/2025
Mettler Toledo International USD 12.82M 54.71M Jun/2026
Myriad Genetics USD 303.9M 33.5M Jun/2026
OraSure Technologies USD 317.78M 4.45M Jun/2026
Quidel USD 1.85B 69.1M Mar/2026
Repligen USD 2.11B 6.57M Jun/2026
Revvity USD 7.18B 67.62M Mar/2026
STAAR Surgical USD 365.4M 13.03M Jun/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Trinity Biotech USD -71.98M 17.26M Dec/2025
Waters USD 15.29B 12.73B Mar/2026